Goals Soccer Centres (GOAL LN) Strategic review / Placing – our initial take is mixed | James Fisher & Sons (FSJ LN) Bolt-on acquisition | Oxford BioMedica (OXB LN) R&D collaboration with Green Cross LabCell | Sigma Capital Group (SGM LN) New strategic partnership with Keepmoat | Summit Therapeutics (SUMM LN) Q1 2017 results | Verona Pharma (VRP LN) Full year results highlight period of impressive development | Xaar (XAR LN) Launch of Thin Film/P4 and strategic partnership
03 Jun 2016
Morning Song
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Goals Soccer Centres (GOAL:LON), 0 | James Fisher and Sons plc (FSJ:LON), 280 | Oxford BioMedica plc (OXB:LON), 202
- Published:
03 Jun 2016 -
Author:
N+1 Singer Team -
Pages:
16
Goals Soccer Centres (GOAL LN) Strategic review / Placing – our initial take is mixed | James Fisher & Sons (FSJ LN) Bolt-on acquisition | Oxford BioMedica (OXB LN) R&D collaboration with Green Cross LabCell | Sigma Capital Group (SGM LN) New strategic partnership with Keepmoat | Summit Therapeutics (SUMM LN) Q1 2017 results | Verona Pharma (VRP LN) Full year results highlight period of impressive development | Xaar (XAR LN) Launch of Thin Film/P4 and strategic partnership